| 摘要 |
<p>The present invention describes novel imidazo-pyridines, -pyridazines, and -triazines of formula (I) wherein A and B can be C or N and D is aryl or heteroaryl or pharmaceutically acceptable salt forms thereof, which are useful as CRF antagonists.</p> |
